FindTrial
Sign In

Clinical study for Myeloproliferative neoplasms

Clinical study for Myeloproliferative neoplasms

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019943
Enrollment
Unknown
Registered
2018-12-09
Start date
2018-12-15
Completion date
Unknown
Last updated
2018-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myeloproliterative neoplasms

Interventions

Case series:Nil

Sponsors

Tianjin Medical University Second Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 89 Years

Inclusion criteria

Inclusion criteria: 1. meet the diagnostic criteria of MPN of WHO in 2016; 2. Aged more than 18 years old.

Exclusion criteria

Exclusion criteria: Do not tolerate bone marrow puncture, venous bleeding and pregnant women

Design outcomes

Primary

MeasureTime frame
next generation sequencing;—

Countries

China

Contacts

Public ContactJie Bai

Tianjin Medical University Second Hospital

janebai86@126.com+86 13820525296

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026